PU.1 furactions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors

Immunity

Volumn 6, Issue 4, 1997, Pages 437-447

  Scott, Edward W ^a,b   Fisher, Robert C ^a,b   Olson, Marilyn C ^a   Kehrli, Eli W ^a   Simon, M Celeste ^a   Singh, Harinder ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; IKAROS TRANSCRIPTION FACTOR; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN; ZFPN1A1 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHIMERA; DEVELOPMENT; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; HEMATOPOIESIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECT; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; LYMPHOID TISSUE; MALE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; RADIATION CHIMERA;

ANIMALS; BONE MARROW CELLS; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; CHIMERA; DNA-BINDING PROTEINS; EMBRYO; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FEMALE; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; IKAROS TRANSCRIPTION FACTOR; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PROTO-ONCOGENE PROTEINS; RADIATION CHIMERA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0030611964     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80287-3     Document Type: Article

References (33)

1. Brass, A.L., Kehrli, E., Eisenbeis, C.F., Storb, U., and Singh, H. (1996). Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 10, 2335-2347.
2. Chen, H., Ray-Gallet, D., Zhang, P., Hetherington, C.J., Gonzalez, D.A., Zhang, D.E., Moreau-Gachelin, F., and Tenen, D.G. (1995). PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 11, 1549-1560.
3. Cumano, A., and Paige, C. (1992). Enrichment and characterization of uncommitted B-cell precursors from fetal liver at day 12 of gestation. EMBO J. 11, 593-601.
4. Cumano, A., Paige, C., Iscove, N., and Brady, G. (1992). Bipotential precursors of B cells and macrophages in murine fetal liver. Nature 356, 612-615.
5. Galson, D., Hensold, J., Bishop, T., Schalling, M., D'Andrea, A., Jones, C., Auron, P., and Housman, D. (1993). Mouse b-globulin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol. Cell. Biol. 13, 2929-2941.
6. Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., and Sharpe, A. (1994). The Ikaros gene is required for the development of all lymphoid lineages. Cell 79, 143-156.
7. Hromas, R., Orazi, A., Neiman, R., Maki, R., Van Beveran, C., Moore, J., and Klemsz, M. (1993). Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood 82, 2998-3004.
8. Huang, M., and Auerbach, R. (1993). Identification and characterization of hematopoietic stem cells from the yolk sac of the early mouse embryo. Proc. Natl. Acad. Sci 90, 10110-10114.
9. Jordan, C., McKearn, J., and Lemischka, I. (1990). Cellular and developmental properties of fetal hematopoietic stem cells. Cell 61, 953-963.
10. McKearn, J., Baum, C., and Davie, J. (1984). Cell surface antigens expressed by subsets of pre-B cells and B cells. J. Immunol. 132, 332-339.
11. McKercher, S., Torbett, B., Anderson, K., Henkel, G., Vestal, D., Baribault, H., Klemsz, M., Feeney, A., Wu, G., Paige, C., and Maki, R. (1996). Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658.
12. Moreau-Gachelin, F. (1994). Spi-1/PU.1: an oncogene of the ets family. Biochim. Biophys. Acta 1198, 149-163.
13. Morrison, S., Hemmati, H., Wandycz, A., and Weissman, I. (1995). The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl. Acad. Sci. 92, 10302-10306.
14. Morrison, S.J., and Weissman, I.L. (1994). The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1, 661-673.
15. Mucenski, M., Mclain, K., Kier, A., Swerdlow, S., Schreiner, C., Miller, T., Pietryga, D., Scott W., and Potter, S. (1991). A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65, 677-689.
16. Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M., Fields, L., Lucas, P., Stewart, V., Alt, F., and Loh, D. (1993). Disappearance of the lymphoid system in Bcl-2homozygous mutant chimeric mice. Science 261, 1584-1588.
17. Ogawa, M. (1993). Differentiation and proliferation of hematopoietic stem cells. Blood 81, 2844-2853.
18. Okuda, T., van Deursen, J., Hiebert, S., Grosveld, G., and Downing, J. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
19. Olson, M.C., Scott, E.W., Hack, A.A., Su, G.H., Tenen, D.G., Singh, H., and Simon, M.C. (1995). PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3, 703-714.
20. Papaioannou, V., and Johnson, R. (1993). Production of chimeras and genetically defined offspring from targeted ES cells. In Gene Targeting: A Practical Approach, D. Rickwood and B.D. Hames, eds. (New York: Oxford University Press), pp. 107-146.
21. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F., and Orkin, S. (1996). The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86, 47-57.
22. Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R., Metcalf, D., and Begley, C. (1995). Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. 92, 7075-7079.
23. Scott, E., Simon, M., Anastasi, J., and Singh, H. (1994). Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577.
24. Shivdasani, R., Mayer, E., and Orkin, S. (1995). Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 373, 432-434.
25. Shivdasani, R., and Orkin, S. (1996). The transcriptional control of hematopoiesis. Blood 87, 4025-4039.
26. Singh, H. (1996). Gene targeting reveals a hierarchy of transcription factors regulating specification of lymphoid cell fates. Curr. Opin. Immunol. 8, 160-168.
27. Spangrude, G. (1994). Biological and clinical aspects of hematopoietic stem cells. Annu. Rev. Med. 45, 93-104.
28. Tavassoli, M. (1991). Embryonic and fetal hemopoiesis: an overview. Blood Cells 1, 269-281.
29. Tsai, F., Keller, G., Kuo, F., Weiss, M., Chen, J., Rosenblatt, M., Alt, F., and Orkin, S. (1994). An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221-226.
30. Uchida, N., Fleming, W., Alpern, E., and Weissman, I. (1993). Heterogeneity of hematopoietic stem cells. Curr. Opin. Immunol. 5, 177-184.
31. Urbánek, P., Wang, Z.-Q., Fetka, I., Wagner, E., and Busslinger, M. (1994). Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901-912.
32. Warren, A.J., Colledge, W.H., Carlton, M.B.L., Evans, M.J., Smith, A.J.H., and Rabbitts, T.H. (1994). The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell 78, 45-57.
33. Whitney, J. (1978). Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine. Biochem. Genet. 16, 1184-1197.